Superficial Esophageal Neoplasia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Superficial Esophageal Neoplasia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06077981

Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections

This is a randomized, single-center clinical trial that will compare the efficacy of two substances used in the submucosal cushion formation stage of endoscopic…

Brazil30 participantsStarted 2023-06-19

Treatment: Submucous Endoscopic Dissection with hydroxyethylamide, Submucous Endoscopic Dissection with Hyaluronic acid (TS-905 Blue Eye)

All recent trials (19 shown)

TerminatedPhase 3

NCT04689594

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissecti…

The purpose of this study is to evaluate the efficacy and safety of esophageal epithelial regenerative treatment by the transplantation of the product, CLS2702C…

Japan1 participantsStarted 2021-02-04

Treatment: CLS2702C/CLS2702D

Not Yet RecruitingNot Applicable

NCT07343869

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

In France in 2018, there were an estimated 2,074 new cases of esophageal adenocarcinoma and 3,224 cases of squamous cell carcinoma. The estimated deaths from es…

France750 participantsStarted 2026-02-01

Superficial Esophageal Neoplasia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections

All recent trials (19 shown)

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissecti…

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections

All recent trials (19 shown)

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissecti…

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia

Status of Superficial Esophageal Cancers Treated by Endoscopy "OESOFARE"

Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms

Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）

Hematoporphyrin Photodynamic Therapy for Esophageal Cancer

Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma

Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma

Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carc…

A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Ce…

Staging of Superficial EAC Using VLE

Mapping of Lymph Node Metastasis and Survival For pN+ Superficial Esophageal Squamous Cell Carcinoma

Narrow Band Imaging (NBI) Against Lugol for Squamous Esophageal Cancer

Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer

Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear Fluids

Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously

Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma